Evidence map›Paper›PMID 31468514›Full record

ArticleFEBS letters2020

Notch signalling is a potential resistance mechanism of progenitor cells within patient-derived prostate cultures following ROS-inducing treatments.

John R Packer, Adam M Hirst, Alastair P Droop, Rachel Adamson, Matthew S Simms, Vincent M Mann, Fiona M Frame, Deborah O'Connell, Norman J Maitland

Open access · hybridAbstract read
In one paragraph

Article in FEBS letters, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Ubiquitin Proteasome Gene Signatures in Ependymoma Molecular Subtypes.International journal of molecular sciences · 2022
    Review
  4. Promoting the adhesion of human gingival epithelial cells on titanium surface by non-thermal atmospheric plasma irradiation.Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology · 2022
    Article
  5. Article
  6. Review
  7. Reproducibility of 'COST reference microplasma jets'.Plasma sources science & technology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

John R PackerCancer Research Unit, Department of Biology, University of York, UK.
Adam M HirstCancer Research Unit, Department of Biology, University of York, UK.
Alastair P DroopFaculty of Biological Sciences, University of Leeds, UK.
Rachel AdamsonCancer Research Unit, Department of Biology, University of York, UK.
Matthew S SimmsDepartment of Urology, Castle Hill Hospital (Hull and East Yorkshire Hospitals NHS Trust), Cottingham, UK.
Vincent M MannCancer Research Unit, Department of Biology, University of York, UK.
Fiona M FrameCancer Research Unit, Department of Biology, University of York, UK.ORCID 0000-0002-2377-1110
Deborah O'ConnellDepartment of Physics, York Plasma Institute, University of York, UK.
Norman J MaitlandCancer Research Unit, Department of Biology, University of York, UK.
Yorkshire Cancer Research · GBHull and East Yorkshire Hospitals NHS Trust · GBUniversity of Leeds · GBUniversity of York · GB

Funding

Cancer Research UK c219/a12497Medical Research Council MR/S00386X/1Medical Research Council MR/S00386X/2
6 · The paper itself

Abstract

Low Temperature Plasma (LTP) generates reactive oxygen and nitrogen species, causing cell death, similarly to radiation. Radiation resistance results in tumour recurrence, however mechanisms of LTP resistance are unknown. LTP was applied to patient-derived prostate epithelial cells and gene expression assessed. A typical global oxidative response (AP-1 and Nrf2 signalling) was induced, whereas Notch signalling was activated exclusively in progenitor cells. Notch inhibition induced expression of prostatic acid phosphatase (PAP), a marker of prostate epithelial cell differentiation, whilst reducing colony forming ability and preventing tumour formation. Therefore, if LTP is to be progressed as a novel treatment for prostate cancer, combination treatments should be considered in the context of cellular heterogeneity and existence of cell type-specific resistance mechanisms.

Indexed as

Acid PhosphataseCell DeathCell DifferentiationCell Line, TumorCell ProliferationEpithelial CellsGene Expression Regulation, NeoplasticHumansMaleNF-E2-Related Factor 2Plasma GasesProstateProstatic NeoplasmsRadiation ToleranceReactive Nitrogen SpeciesReactive Oxygen SpeciesAcid PhosphataseNFE2L2 protein, humanNF-E2-Related Factor 2Plasma Gasesprostatic acid phosphataseReactive Nitrogen SpeciesReactive Oxygen SpeciesReceptors, NotchTranscription Factor AP-1Low temperature plasmaNotch signallingprogenitor cellsprostate cancerreactive oxygen speciesTherapy resistance

Identifiers

PMID31468514
PMCPMC7003772
OpenAlexW2970762763

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.